Hong Kong Airlines to start daily service to Manila from June 2018
Apr 20, 2018

HONG KONG, April 20, 2018 /PRNewswire/ -- Hong Kong Airlines will operate daily flights between its home base of Hong Kong and Manila, the capital of the Philippines from 1 June 2018 - the latest addition to the airline's expanding network.

According to official figures by the Hong Kong Tourism Board, visitor arrivals from the Philippines climbed to 894,489 in 2017 - a 13% growth from that in 2016. Hong Kong Airlines' new service will meet the increasing travel demand from the Philippines to Hong Kong and beyond, including popular destinations like Los Angeles, San Francisco and Vancouver in North America.

Mr Michael Ma, Director of Commercial at Hong Kong Airlines said: "Demand for flights between the Philippines and Hong Kong has been growing steadily, and we are pleased to offer customers more travel options than ever. Our entry into a new market marks an exciting milestone for us, and we look forward to developing this even further."

As one of the most densely populated cities in the world, Manila is the business and commercial centre of the Philippines with key industries such as banking and finance, retail, transportation, tourism, and real estate. The capital city is also home to the largest seaport in the country, making it one of the prime shipping gateways to the Philippines.

Hong Kong Airlines will deploy an Airbus A320 on the new route, which will be outfitted with a single-class configuration and offer 174 seats in Economy Class.

The schedule* for the new service can be seen below (All times local):

Flight Sector

Flight Number








Tue, Fri, Sun




Mon, Wed, Thu, Sat






For more details and sales, please visitwww.hongkongairlines.com, or contact us via the Hong Kong Airlines Call Centre hotline (852) 3916 3666 (Hong Kong)

Travellers may also use this opportunity to sign up for Hong Kong Airlines' "Accelerate" programme, a new loyalty initiative that rewards frequent flyers with instant travel benefits, and to quickly become top tier members of the Fortune Wings Club.

About Hong Kong Airlines

Established in 2006, Hong Kong Airlines is a full-service airline firmly rooted in Hong Kong. The airline flies to nearly 40 destinations across Asia Pacific and North America, and currently maintains 78 interline and 18 codeshare agreements with multiple airline partners. Hong Kong Airlines has been awarded the four-star rating by Skytrax. Hong Kong Airlines has also been recognised for its excellent On-Time Performance, having been ranked by air travel intelligence company OAG as Asia's most punctual airline and the second globally in 2017.

For more information, please visit:

Instagram ID: hkairlines
Twitter: @hkairlines

Source: Hong Kong Airlines

- ASIA TODAY News Global Distribution http://www.AsiaToday.com

ASTRI Wins 14 Awards at the International Exhibition of Inventions of Geneva
Apr 16, 2018

HONG KONG, April 16, 2018 /PRNewswire/ -- The Hong Kong Applied Science and Technology Research Institute (ASTRI) has won 14 awards at the 46th International Exhibition of Inventions of Geneva. With three of these 14 awards being accompanied by a Congratulations from the Jury, ASTRI is one of the most awarded organisations among Hong Kong participants in the Exhibition.

Held annually in Geneva, the International Exhibition of Inventions is recognised as the most revered and specialised event of its kind in the world. It attracts exhibitors from around the globe who showcase their inventions and innovations to a large global audience. For this year, there were 822 exhibitors and a thousand inventions on display in the Exhibition. A Hong Kong delegation comprising around 15 institutions and universities won 98 awards. Among them, ASTRI received three Gold Medals with Congratulations of the Jury, eight Gold medals and three Silver medals. This remarkable feat made ASTRI one of the most awarded organisations among the Hong Kong exhibitors.

The three ASTRI projects winning Gold Medals with Congratulations of the Jury were: B-TrunC Base-station for mission critical communications which enables fast, reliable, low-latency communications; Advanced Safety Design for Rechargeable Battery to prevent accidents causing by overheating of battery during recharging; and Non-invasive Bloodless Glucometer.

Commenting on this special achievement, Mr Wong Ming-yam -- ASTRI's Chairman said: "The International Exhibition of Inventions in Geneva is a highly respected international platform for innovators from around the world. ASTRI is honoured and delighted to stand out among many world-class inventors and institutions with 14 prestigious awards. This recognition of our innovative endeavours once again demonstrates ASTRI's R&D capability and strength. ASTRI will continue to dedicate its efforts to help enhance Hong Kong's global competitiveness through applied research."

ASTRI's winning projects at the International Exhibition of Invention in Geneva:

Gold Medal with the Congratulations of the Jury

1.  B-TrunC base-station for mission critical communications

2. Advanced safety design for rechargeable battery

3. Non-invasive bloodless glucometer

Gold Medal

4. Panoramic video processor

5. Barcode-free retail scanner

6. 3D high power electronic modules

7. Narrowband internet of things

8. Glass surface defects inspection system

9. Automated processing platform for handwritten Chinese character recognition

10. Vehicle detection, tracking and localisation based on enhanced anti-perspective transformation

11. Smart data indexing system for mobile devices

Silver Medal

12. Apparatus and method for fast evaluation of plating additives performance in microvia filling

13. Touch and motion detection using surface map, object shadow and a single camera

14. All-in-one Virtual Reality based Head Mount Display System (HMD)

The International Exhibition of Inventions in Geneva is organised under the patronage of the World Intellectual Property Organization (WIPO), Swiss Federal Government, the State, and the City of Geneva. With its unparalleled profile and global stature, the Exhibition is acknowledged as the most important show of inventions anywhere in the world. It is also the most international, with the participation of more than 45 countries and territories.


Hong Kong Applied Science and Technology Research Institute Company Limited (ASTRI) was founded by the Government of the Hong Kong Special Administrative Region in 2000 with the mission of enhancing Hong Kong's competitiveness in technology-based industries through applied research. ASTRI's core R&D competences in various areas are organised under seven Technology Divisions, namely Communications Technologies, Electronics Components, Mixed Signal Systems IC, Advanced Digital Systems, Opto-electronics, Security and Data Sciences, and Intelligent Software and Systems. Five areas of applications including financial technologies, intelligent manufacturing, next generation network, health technologies, and smart city are identified for major pursuit. Please visit www.astri.org for further information about ASTRI.

Source: Hong Kong Applied Science and Technology Research Institute

Suprema launches the BioLite N2 at ISC West 2018
JCN Newswire
Apr 16, 2018

SEOUL, KOREA - (ACN Newswire) - Suprema, a global leader in biometrics and security, launched the BioLite N2, a mullion-type access control and time attendance terminal featuring the world's most advanced fingerprint technology with a rugged IP67 weatherproof structure, at ISC West 2018 in Las Vegas.

BioLite N2 is designed for both enterprise access control systems and time attendance applications, combining Suprema's industry-leading technologies with innovative features. Loaded with a powerful 1.2GHz CPU and massive 4GB memory, BioLite N2 achieves incredible matching speeds of up to 20,000 matches per second, accommodates up to 10,000 users and provides instant matching results with minimal lag time.

For reliable operation under harsh conditions including outdoor installation or temperature extremes, BioLite N2 features a rugged IP67 structure and a class-leading operating range of -20 degrees ~ 50 degrees Celsius, or -4 degrees ~ 122 degrees Fahrenheit. The device also features an illuminated keypad and a high-contrast GUI for better visibility under various lighting conditions.

BioLite N2 provides exceptional performance and accuracy on dry finger skin, particularly in the winter season when humidity drops. With its recent advances in image processing and sensor technology, the company's current 2nd generation fingerprint terminal yields up to 5 times greater accuracy on dry skin or under cold weather conditions than competing units (in terms of false rejection rate).

"The new BioLite N2 is designed to provide the best reliable fingerprint matching performance in any environment, including outdoor installation and extreme weather conditions. As is common with Suprema's other 2nd generation fingerprint IP readers, BioLite N2 provides up to 200% faster matching speed than its predecessor BioLite Net, and easily outperforms competing products," said HC Kim, Director of Global Business at Suprema.

At the show, Suprema also showcased its latest range of centralized access control devices including the CoreStation access control unit, fingerprint readers, RFID/keypad readers and the updated BioStar 2 with access management software.

To experience the latest Suprema products and technologies, please book at the link below or visit the Suprema booth (#28065) at ISC West 2018.http://web.supremainc.com/bookameeting_ISCWest2018_web

About Suprema Inc.

Suprema is a leading global provider of biometrics and security. By combining world renowned biometric algorithms with superior engineering, Suprema continually designs and develops industry leading products and solutions. Suprema's extensive range of portfolio includes biometric access control systems, time & attendance solutions, fingerprint live scanners, mobile authentication solutions and embedded fingerprint modules. Suprema has worldwide sales network in over 130 countries and is one of the world's Top 50 security manufacturer in its turnover (ranked in A&S's Security 50, 2010-2017). For more information, please visitwww.supremainc.com.

Andy Ahn
Head of Marketing, Suprema Inc.
Email: andyahn@suprema.co.kr

- ASIA TODAY News Global Distribution http://www.AsiaToday.com

Company JCN Newswire
Contact Tiara Liu
Telephone +81-3-5791-1821
E-mail info@japancorp.net
Automobili Pininfarina, the World’s Newest Sustainable Luxury Car Brand, Launched by Mahindra
Apr 13, 2018

Automobili Pininfarina to launch electric hypercar in 2020, offering extreme performance
New company to leverage Pininfarina’s legendary automotive design expertise

ROME--(BUSINESS WIRE)--Mahindra & Mahindra Ltd., part of the $19 billion Mahindra Group, today announced the launch of Automobili Pininfarina, the world’s newest sustainable luxury car brand.

Automobili Pininfarina, promoted by Mahindra & Mahindra Ltd., will be based in Europe. The company will design, engineer and manufacture high technology, extreme performance, luxury electric vehicles for the most discerning global customers.

Automobili Pininfarina will combine Pininfarina’s legendary automotive design prowess with Mahindra’s growing electric vehicle (EV) expertise gained from its participation in the Formula E electric racing car championship. Automobili Pininfarina plans to launch its first model, a ‘Pininfarina’ badged electric hypercar, in 2020.

Paolo Pininfarina, Chairman, Pininfarina SpA, “We are pleased to welcome the new company, Automobili Pininfarina which represents an additional client for Pininfarina SpA, joining the list of the many prestigious car makers for which we will be designing cars in the future. This project helps me and my family to realize my grandfather’s dream of seeing outstanding innovative cars solely branded Pininfarina on the roads.”

According to Anand Mahindra, Chairman, Mahindra Group, “Italy’s renowned design expertise produces objects of true beauty and unique style. Drawing upon the pedigree and design vocabulary of the Pininfarina aesthetic heritage we will develop a rare collector’s item that only a handful of connoisseurs will ever own. It will be an innovative and pioneering product powered by high technology. The Mahindra Group has bet big on electric vehicles. They are the future, and when power, beauty and high end EV technology come together in one car – that will be the perfect luxury vehicle, that will give car lovers the freedom to roam without impacting the planet adversely.”

Dr. Pawan Goenka, Managing Director, Mahindra & Mahindra Ltd. and Chairman, Mahindra Racing, said, “We believe that this is the perfect time to launch Automobili Pininfarina, given Mahindra’s growing EV expertise from our participation in Formula E racing where we are currently second in the constructors’ and drivers’ championships, and Pininfarina’s design expertise that will allow us to develop stylish, extreme-performance, electric vehicles for global markets.”

Automobili Pininfarina will be led by Michael Perschke, as its Chief Executive Officer. Michael brings with him over 25 years of experience with premium German brands at both headquarter director-level as well as in various market roles. He was the Managing Director of Audi in India and a member of the Management Board of Volkswagen Group Sales India, from 2010 to 2013. Michael will play an instrumental role in developing the strategy for Automobili Pininfarina. He will be joined by Per Svantesson as Chief Operating Officer. Per brings with him relevant experience including his stints with the Volvo Group and NEVS.

Michael Perschke, CEO, Automobili Pininfarina, commented, “Establishing Automobili Pininfarina as a leading sustainable luxury brand is our strategic vision and will be a dream come true. It will combine 88 years of iconic design heritage with leading edge electric vehicle competence of the Mahindra Group and Mahindra Formula E racing. It’s a powerful combination. I am honoured to lead Automobili Pininfarina and our ambition is to make it a respected and desirable brand recognized by connoisseurs who value design heritage, substance and sustainable high performance EV technology.”

About Mahindra

The Mahindra Group is a USD 19 billion federation of companies that enables people to rise through innovative mobility solutions, driving rural prosperity, enhancing urban living, nurturing new businesses and fostering communities. It enjoys a leadership position in utility vehicles, information technology, financial services and vacation ownership in India and is the world’s largest tractor company, by volume. It also enjoys a strong presence in agribusiness, aerospace, commercial vehicles, components, defence, logistics, real estate, renewable energy, speedboats and steel, amongst other businesses. Headquartered in India, Mahindra employs over 240,000 people across 100 countries.

Learn more about Mahindra onwww.mahindra.com / Twitter and Facebook: @MahindraRise

Mahindra & Mahindra Ltd.
Varsha Chainani, Group Communications
(M) +91 9987340055

- ASIA TODAY News Global Distribution http://www.AsiaToday.com

Nature Cell and Biostar Stem Cell Research Institute Begin World’s First Stem Cell-Based Regenerative Treatment for Alzheimer's Disease in Japan
Apr 13, 2018
  • Autologous adipose tissue-derived mesenchymal stem cells applied to Alzheimer’s patients for the first time
  • World’s first intravenous injection of stem cells over 10 applications developed by Biostar Stem Cell Research Institute and Dr. Jeong-Chan Ra
  • Treatment can be applied to mild-to-moderate Alzheimer’s patients; around 80 patients booked for the treatment until May

    SEOUL, South Korea--(BUSINESS WIRE)--South Korea’s Biostar Stem Cell Research Institute (CEO: Jeong-Chan Ra), jointly operated by Nature Cell and Rbio, today announced that Trinity Clinic Fukuoka, a partner hospital in Japan, received approval for the application of regenerative medicine in Alzheimer’s disease and officially began stem cell treatment as of April 12.

    Earlier in March, Trinity Clinic Fukuoka received approval from the Kyushu Certified Special Committee for Regenerative Medicine for the safety and effectiveness in applying regenerative medicine to Alzheimer’s patients, based on the Act on the Safety of Regenerative Medicine in Japan. The evaluation results were delivered to the Kyushu branch office of Japan’s Ministry of Health, Labor and Welfare (MHLW), and the treatment was officially approved by the Ministry on April 11.

    Trinity Clinic Fukuoka started the first stem cell treatment to three Korean Alzheimer’s patients, who were each administered with 200 million cells over two hours. They will receive treatment every two weeks, for a total of 10 treatments.

    The stem cell therapy of Alzheimer's disease is to administer autologous adipose tissue-derived mesenchymal stem cells intravenously. This is a novel approach to treating Alzheimer’s disease, using unique stem cell technologies that have been developed over more than 13 years. The treatment involves a number of patented technologies, such as methods for producing stem cells of a size suitable for intravascular administration, culture medium compositions for regenerating stem cells, and compositions for enhancing storage stability of serum-containing stem cells. Dr. Jeong-Chan Ra has been testing intravenous injections in his own body since 2008 to evaluate the safety of this process. Moreover, the safety of intravenous infusion has been established in clinical trials in the United States. Published clinical studies show that multiple injections are unlikely to cause cancer in humans.

    Unlike the existing treatment for Alzheimer’s disease that only slows the progression of the illness, stem cell therapy is expected to be a fundamental cure for the disease. Dr. Ra’s research team tested animals that have Alzheimer's disease and proved the effectiveness of the stem cell treatment of Alzheimer’s disease as well as the prevention of Alzheimer’s disease. Dr. Ra’s study was also published in the international journal Plos-One in 2012, and the treatment is known to perform multiple functions including anti-inflammation, cerebral vascular regeneration, and brain cell protection and regeneration.

    Stem cell therapy can be applied to mild-to-moderate Alzheimer’s patients who are aged 65 or older. Patients with early-stage Alzheimer’s disease who are 55 years or older can also receive the stem cell treatment if their family members or guardians agree to the treatment. However, pregnant women and those with serious diabetes or cardiac failure cannot receive the treatment.

    Chang-hee Yang, CEO of Trinity Clinic Fukuoka, said, “It is a great honor to become the first medical institute to use stem cell technology in treating Alzheimer’s patients. Reservations for around 80 patients have already been received for treatment until May, and additional inquiries are steadily being received about reservations for the therapy. As the world is seeing accelerated growth in aging populations and a drastic increase in Alzheimer’s patients, the need for treating Alzheimer’s patients can be met at Trinity Clinic Fukuoka.”

    Dr. Jeong-Chan Ra, who developed the stem cell treatment for Alzheimer’s disease, explained his vision, saying, “This is the first step in our project to overcome Alzheimer’s, which was launched with our commitment to conquer this disease. With the start of stem cell treatment, Biostar will support Alzheimer’s patients from all over the world – including Japan, Korea, China, and the U.S., starting in Japan – to restore their memory and ultimately their humanity.”

    Residents of Japan who are suffering from Alzheimer’s can receive treatment by directly contacting Trinity Clinic Fukuoka. Residents in South Korea, the United States and other countries can inquire with Biostar Korea for a treatment reservation.

    Nature Cell

    Nature Cell (KOSDAQ: 007390) is a high-tech bio enterprise, a leader of stem cell business, stem cell drugs and treatment technology development, and stem cell culture medium cosmetics. Nature Cell also manufactures and sells health supplements and foods that help adults improve their memory. Furthermore, Nature Cell is a member of the stem cell network Biostar, along with Rbio, GDFI Braincell Laboratory, Stem Cell Research Institute, Stemcell Life Foundation, Bethesda Hospital, R-Japan and Medicorp, which are entities committed to stem cell research for treating incurable diseases. More information about Nature Cell can be found atwww.naturecell.co.kr.

    Biostar Stem Cell Research Institute

    Biostar Stem Cell Research Institute is jointly run by Nature Cell and RBio, the adult-derived stem cells research firm. The institute has cutting edge technologies and equipment for stem cell separation, cultivation and storage, and strives to develop technologies for commercialization of JointStem, an autologous stem cell-based medicine for degenerative arthritis patients; AstroStem, treatment of spinal injury patients and Alzheimer's disease; VascoStem, a candidate for a new drug to treat Burger’s disease, which causes ischaemic necrosis, and the Parry Romberg disease, which causes anti-facial atrophy. More details about Biostar Stem Cell Research Institute can be found athttp://ko.stemcellbio.com.

    Nature Cell
    Sanghoon Song
    Access Communication & Consulting Co.
    Soyeon Kim, +82-10-9256-6285
    Sehui An, +82-10-7749-3298

    - ASIA TODAY News Global Distribution http://www.AsiaToday.com

    New compound could improve stroke patient recovery, Japanese researchers say
    JCN Newswire
    Apr 11, 2018

    A new compound shows promise for improving motor function recovery for stroke patients in combination with rehabilitation therapy. Human clinical trials for a new drug are underway.

    YOKOHAMA - (ACN Newswire) - A team of Japanese researchers have developed a new compound that enhanced motor function recovery after brain damage in animal tests, according to a study published in the journal Science.

    The small-molecule compound, called edonerpic maleate, was developed by a research team led by Yokohama City University and Toyama Chemical Co., Ltd. in Japan. When administered to rodents and monkeys undergoing rehabilitation for brain damage, both groups of animals showed greater and faster recovery of motor function than those with just rehabilitation alone.

    Toyama Chemical has already completed a clinical trial for the drug in healthy people, and plans to next conduct a clinical trial with stroke patients. The Phase 2 trial is expected to evaluate the drug's safety and ability to accelerate rehabilitation in humans. The drug must complete three phases of successful trials before it can be approved as a medication.

    More than 17 million people worldwide suffer from strokes each year. The majority of strokes block blood flow to the brain, which can lead to severe paralysis. Loss of function depends on the size and location of the affected area. Some available treatments are limited to the few hours following a stroke. Long-term treatment often involves different types of physical therapy, and motor function recovery varies from patient to patient.

    In this new study, the researchers describe how edonerpic maleate helps accelerate recovery of motor function. For example, macaque monkeys doing physical therapy and receiving edonerpic maleate were able to pinch small food with their fingers within a month of starting treatment. Recovery of such fine motor movements is often difficult for stroke patients.

    "I hope this drug will help a lot of patients who suffer from paralysis after stroke," said Professor Takuya Takahashi, of Yokohama City University Graduate School of Medicine, who led the research.

    Notably, the small-molecule compound shows positive results even when treatment started a month after the induction of brain damage - not just hours. This has the potential to boost recovery prospects for many stroke patients.

    The compound appears to work in tandem with rehabilitation to enhance neural plasticity. Neural plasticity is the brain's ability to learn and adapt in response to experience. Brain cells affected by stroke cease to function normally within seconds of the trauma. However, the brain can create new pathways between neurons with external stimuli, in this case, physical rehabilitation - this is the essence of neural plasticity.

    Edonerpic maleate helps this process by facilitating the delivery of an important neurotransmitter receptor, called AMPA receptor, to the structures called synapses, which mediate information between neurons. The AMPA receptors are very important for signal transmission and information processing. They receive signals from glutamate, a major neurotransmitter, and help transmit the glutamate signal to the next neuron. By helping build up AMPA receptors at synapses in conjunction with rehabilitative training, edonerpic maleate helps increase the potential for a signal transmission and neuron response.

    The researchers further determined that edonerpic maleate works by binding to an intracellular protein called collapsin-response-mediator-protein 2 (CRMP2), which is related to synaptic plasticity. Mice lacking CRMP2 protein did not show an increase in AMPA receptors nor recovery of motor function, even with edonerpic maleate, indicating that CRMP2 is critical for the compound to work.

    The research was done in collaboration with Japan's National Institute of Advanced Industrial Science and Technology, and the National Institutes of Biomedical Innovation, Health, and Nutrition.

    Journal Reference:
    Abe, H. et al. "CRMP2-binding compound, edonerpic maleate, accelerates motor function recovery from brain damage." Science April 6, 2018 Vol. 360, Issue 6384, pp. 50-57 DOI: 10.1126/science.aao2300

    Media Contacts:
    Makoto Watanabe
    Supervisor, Research Planning and University-Industry Cooperation Division
    Yokohama City University
    E-Mail: kenki@yokohama-cu.ac.jp

    Toyama Chemical Co., Ltd.
    General Affairs and Personnel Department
    E-Mail: tc-info-toyama@fujifilm.com

    About Yokohama City University:
    Located in the international city of Yokohama, Yokohama City University has 4 campuses, 3 faculties, 5 graduate schools, 2 affiliated research centers, and 2 affiliated hospitals that serve as the bases for education, research, and medical care. Specifically, medical science research is led by the Advanced Medical Research Center. Additional information about Yokohama City University is available through its website at:https://www.yokohama-cu.ac.jp/en/

    - ASIA TODAY News Global Distribution http://www.AsiaToday.com

    Company JCN Newswire
    Contact Tiara Liu
    Telephone +81-3-5791-1821
    E-mail info@japancorp.net
    Dusit International Introduces New Hotel Brand for 'Millennial-minded' Travellers
    JCN Newswire
    Apr 06, 2018

    ASAI Hotels to offer authentic local experiences in the world's most vibrant neighbourhoods

    BANGKOK, Apr 5, 2018 - (ACN Newswire) - Dusit International, one of Thailand's foremost hotel and property development companies, has introduced ASAI Hotels, a distinctive new brand designed to link curious, millennial-minded travellers with authentic local experiences in vibrant cities and resort destinations worldwide.

    Set to officially launch in Q1 2019 with its first hotel in Bangkok's renowned Chatuchak Market, ASAI Hotels embraces a sustainable, community-focused concept, with each property designed to reflect the culture and heritage of its location through collaborations with local artisans.

    In line with the four core pillars of the brand - Thoughtful Essentials, Common Areas, Locally Inspired and Connected Community - each hotel will feature compact rooms (approximately 15 m2), whose contemporary design will emphasize key features like superior quality beds and high pressure rain showers. A large mixed-use space, meanwhile, will include a cosy and efficient work space, a leisure area, and a restaurant concept curated by local chefs who champion sustainability.

    In the upcoming Chatuchak hotel, which is the only hotel to be located within the world-famous market, this includes an eatery developed by Bangkok-based chefs and restaurateurs, Jarrett Wrisley and Paolo Vitaletti, whose own restaurants, Soul Food Mahanakorn and Appia, are renowned for their sustainable approach to cooking. Their menu at ASAI Chatuchak will highlight produce from Thailand's Royal Projects.

    Each ASAI hotel worldwide will leverage technology to streamline the booking and stay experience. This includes the implementation of self check-in kiosks, and exclusive online guides that link guests with authentic local experiences and lesser-known, but Instagram-worthy, attractions. ASAI will also link with selected local online start-ups, such as TakeMeTour in Thailand, to offer personalised excursions.

    Staff at each property will be hired for personality as much as experience, and they will very much be the face of the brand, expected to be passionate about their neighbourhoods and always ready to share their knowledge with guests.

    Alongside ASAI Chatuchak, five more properties are already confirmed in the pipeline. This includes three ASAI Hotels in Cebu, Philippines (in Lapu-Lapu, Oslob, and the city centre); one hotel in Yangon, Myanmar (in the historic Yankin Township); and a second hotel in Bangkok (in the stylish Sathorn district). All are expected to open throughout 2019.

    ASAI Hotels' management team hopes to secure over 10 properties in the pipeline by the end of the year across Southeast Asia and Japan. This includes owned and joint venture properties as well as properties under Hotel Management Agreements. Australia, Europe and Central America are also on the radar for potential projects.

    "Inspired by community, and driven by sustainability, ASAI is an exciting new concept for Dusit that will leverage the company's 70 years of hospitality heritage to deliver a new kind of stay experience in vibrant neighbourhoods worldwide," said Mr Siradej Donavanik, Managing Director of Asai Holdings Co., Ltd., Dusit International. "The brand has been carefully crafted to meet the needs of millennial-minded travellers who seek authentic local experiences, and who appreciate value and quality for money.

    "ASAI is not budget travel - this is an affordable lifestyle brand offering something new, different and bespoke. Our collaborations with local artisans in each destination will ensure each stay is unique, memorable, and definitely worthy of our slogan - Live Local. And everywhere we set foot we will always ensure we have a positive impact."

    Ms Suphajee Suthumpun, Group CEO, Dusit International, said, "In line with our three-pronged strategy for balance, expansion and diversification, the introduction of ASAI Hotels will add an innovative new revenue stream to our company that complements our traditional hospitality offerings and actively responds to the needs and desires of millennial-minded travellers.

    "Recent detailed studies in America have shown that, alongside a desire for local experiences, a majority 35% of this segment prefer to stay in luxury and upscale resorts. The majority also placed cost and security as chief concerns when booking accommodation. ASAI is perfectly positioned to meet these needs, and we look forward to making the brand a huge success."

    Dusit International is currently in a significant growth phase which will see the company's current portfolio of 27 hotels surpass 70 worldwide within the next four years. The company's other hotel brands, which cover luxury and mid-market segments, include: Dusit Thani, Dusit Devarana, Dusit Princess, and dusitD2.

    About Dusit International

    Dusit International was founded in 1948 by Honorary Chairperson Thanpuying Chanut Piyaoui, whose first hotel was the Princess on Bangkok's Charoenkrung Road. Today the company is a leader in hotel management and hospitality education and comprises a unique international portfolio of distinctive hotels and resorts operating under four brands: Dusit Thani, dusitD2, Dusit Princess and Dusit Devarana. The new ASAI Hotels brand is set to open its first property early next year.

    Dusit International currently operates 27 properties worldwide and has over 50 confirmed projects in the pipeline in key destinations such as Bhutan, China, Indonesia, Kenya, Myanmar, Oman, Philippines, Qatar, Saudi Arabia, Singapore, Thailand, and UAE.

    The company also operates the signature Devarana Spa and has a fast-growing Education Division. The latter, established in 1993, comprises Dusit Thani College, which offers vocational and postgraduate hospitality degrees at campuses in Bangkok and Pattaya; and Le Cordon Bleu Dusit Culinary School. For more information, please visitwww.dusit.com.

    - ASIA TODAY News Global Distribution http://www.AsiaToday.com

    Company JCN Newswire
    Contact Tiara Liu
    Telephone +81-3-5791-1821
    E-mail info@japancorp.net
    Pelican BioThermal To Open New Tokyo Service Center
    Apr 05, 2018

    New location to service rapidly expanding Crēdo™ on Demand rental program

    Pelican BioThermal, the global name in temperature controlled packaging, announces the opening of a new service center in Tokyo. The new facility will service reusable Credo Cube parcel shippers, including refurbishment and repair. It will also serve as an additional network station for the company’s rapidly expanding Crēdo™ on Demand rental program, which offers a high performance, flexible rental option for temperature controlled pallet shippers, with global reach.

    “Japan remains the world’s second-largest pharmaceutical market, behind the United States and China tied for first, making Tokyo a logical fit for our next service center.” explained Dominic Hyde, vice president of Crēdo on Demand. “With an aging population to consider, Japan has recently accelerated approvals of new drugs, a change that will influence many aspects of the life science cold chain in Asia, including the need for temperature controlled packaging, like that serviced in our new Tokyo facility.”

    A grand opening event will be held on May 11 to mark the official launch of the new facility, which is one of 12 new Credo on Demand network station openings scheduled for 2018. Other key locations include the recently opened San Diego Service Center with additional facilities to be unveiled in Seoul, Basel, Dublin, Toronto, Frankfurt, Tel Aviv, Indianapolis and others to be named.

    In addition to serving as a network station for the company’s Crēdo on Demand rental program, the new Tokyo service center will provide a variety of options for Pelican BioThermal customers, including conditioning and end of rental drop-off.

    The company also plans to launch over 50 drop points throughout 2018, for end of rental drop-off of their passive temperature controlled containers (including Crēdo™ Cargo and Crēdo™ Xtreme) at new locations spanning Europe, Asia and the Americas.

    The latest location complements the existing and expanding network stations servicing key hubs for pharmaceutical manufacturing and transfer activities and is available to customers worldwide.

    To learn more about the global network of service centers, network stations and drop points, as well as the wide range of Pelican BioThermal offerings, including Crēdo Cargo, Crēdo Xtreme and the Crēdo on Demand rental program, visithttp://pelicanbiothermal.com.

    Pelican BioThermal is a division of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.

    For further information please contact Amanda O’Hare on 01604 250900 or email amandao@rocket-creative.com

    About Pelican Products
    Pelican Products, Inc. is the global leader in the design and manufacture of high performance protective cases, temperature controlled packaging solutions, advanced portable lighting systems and rugged gear for professionals and outdoor enthusiasts. Their products are used by professionals in the most demanding markets including fire safety, law enforcement, defense / military, aerospace, entertainment, industrial and consumer. Pelican™ products are designed and built to last a lifetime. The company operates in 21 countries, with 22 international sales offices and six manufacturing facilities around the globe. In Europe, the company does business under the name Peli Products, S.L.U.

    About Pelican BioThermal
    Pelican BioThermal LLC offers the widest range of temperature controlled packaging and service solutions to the global life sciences industry. The company’s products ensure that delicate biological materials arrive intact and effective, despite exterior environments. Pelican BioThermal is dedicated to developing innovative products designed to fulfill the complex needs of the global life sciences industry. The company’s customers benefit from its extensive expertise in ensuring that temperature stability is maintained throughout the distribution chain. The company also offers a complete portfolio of services and software to support end-to-end temperature-controlled packaging asset management. In Europe, the company does business under the name Peli BioThermal Limited.

    All trademarks are registered and/or unregistered trademarks of Pelican Products, Inc., its subsidiaries and/or affiliates and others.

    - ASIA TODAY News Global Distribution http://www.AsiaToday.com

    Fuji Xerox Revamps Monochrome High-Speed Production Printer Lineup with the New B9 Series
    Apr 05, 2018

    SINGAPORE, April 3, 2018 --( ASIA TODAY )-- Fuji Xerox Asia Pacific Pte Ltd announced today the expansion of its monochrome high-speed production printer line-up, with the launch of the B9136, B9125, B9110, and B9100 Copier/Printers (hereafter, the B9 series) which will be rolled out in phases in the Asia-Pacific region. This launch comes as a response to the growing and diverse monochrome printing needs in the office, graphic arts and critical printing operations market segments.

    While executing critical jobs that require massive amounts of data to be printed within a short period, printers need to operate reliably and yield high productivity. Looking at the current printing industry, Fuji Xerox noted that, despite the expansive use of color printing, the demand for monochrome printing is still strong — especially among producers of manuals, statements, books and comics. In order to help the customers meet their evolving needs, Fuji Xerox has revamped its current monochrome high-speed production printer line-up with the new B9 series – on-demand printers that can handle large amounts in a short period.

    “Building on the success of its predecessor*1, which enjoyed long-term consumer trust and top market share for five consecutive years*2, the newly launched B9 series offers noteworthy enhancements in productivity, reliability, and durability,” said Steve Ford, general manager, production sales and marketing, Fuji Xerox Asia Pacific. “We expect to see strong adoption of this series in Asia Pacific as markets in our region are witnessing robust growth in the key segments for which these printers are designed.”

    High productivity and stability demanded in production printers

    For both single-sided and duplex printing, the B9 series can achieve continuous printing speeds of up to 136 pages per minute (ppm). This high level of productivity is enabled by pairing Fuji Xerox’s very own EA-Eco LGK toner, which has an excellent low-temperature fusing capability, with the B9 series’ ability to administer a stable supply of heat in order to apply the toner efficiently onto the paper — even when printing at high speeds.

    The paper transport system is designed with no sharp curves to ensure smooth paper motion and also a vertically placed paper inversion mechanism for duplex printing so that paper can be sent through at high speeds while minimizing paper jams.

    Higher-quality prints achieved with greater ease

    In order to achieve high resolution printouts of 2,400 x 2,400 dots per inch (dpi) while printing at quick speeds, a VCSEL*3 is used as the light source for the ROS*4 – which functions just like the heart of the printer.

    Using tiny granules measuring 6.5 μm, the EA-Eco LGK toner enables an elegant reproduction of gradations in photos and images, consistent halftones and clear printing of small letters.

    The B9 series also offers a selection of various, different screen settings*5 to ensure high quality printing each time. This includes the Stochastic (or FM) Screen which efficiently aids in moiré reduction, the new Edge Enhancement for fixing jagged edges of thin lines/text outlines, and the Adjust Invert Text/Line Weight setting, which helps improve the visibility of text and lines.

    In-house developed print server with high resolution and integrated workflow system

    With a proven track record amongst production colour printers, Fuji Xerox’s in-house developed controller, the GX Print Server, is now also being utilized in monochrome production printers for the first time ever. The GX Print Server, combined with the improvements made to the product’s hardware, delivers high-quality images and high raster image processing (RIP) speeds of 600 x 600 dpi at eight bit (256 graduation levels). Fuji Xerox’s original HQ Digital Screen Technology (MACS) then also helps create a high-definition, smooth screen image of 2,400 x 2,400 dpi. These data processing technologies all work in tandem to help deliver top quality printing results.

    The B9 series supports the JDF*6 standards of the printing industry and by connecting the printer with the integrated workflow system for printing operations*7, it enables the development of a hybrid workflow that utilises both offset printers and digital printers cohesively.

    *1 D136 Copier Printer
    *2 IDC WW HCP Tracker 2017Q3. As a Xerox Group in the company category for the following requirements: Monochrome Laser, A3 cut Sheet, Monochrome 91+ppm, Light Production/Mid Production/Production. For the five years between 2012 and 2016.
    *3 Vertical Cavity Surface Emitting Laser
    *4 Raster Output Scanner
    *5 Six types when using the PCL driver, 12 types when using the PostScript driver, 10 types when using to the Print Server driver
    *6 Job Definition Format
    *7 Fujifilm WorkFlow XMF by Fujifilm Corporation, linked with EQUIOS and Trueflow SE by SCREEN Graphic Solutions Co., Ltd.

    # # #

    John Tan
    Fuji Xerox Asia Pacific

    - ASIA TODAY News Global Distribution http://www.AsiaToday.com

    TANAKA Begins Sample Shipments of SKe-Lid Glass Lids Made of Quartz with AuSn for Deep Ultraviolet LEDs
    JCN Newswire
    Apr 03, 2018

    Controlling cracks and metallization separation in applications such as semiconductor lasers and automotive sensor devices raises productivity and reduces costs

    TOKYO - (ACN Newswire) - Tanaka Holdings Co., Ltd. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Akira Tanae) announced today that Tanaka Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku, Tokyo; Representative Director and CEO: Akira Tanae), which operates the Tanaka Kikinzoku Group's manufacturing business, began sample shipments of SKe-Lid, a newly-developed glass lid made of quartz with gold-tin (AuSn) for use with deep ultraviolet[1] light emitting diodes (LEDs).

    Deep ultraviolet LEDs are a next-generation light source expected to replace mercury lamps and have various applications including water disinfection in industry and air disinfection systems in healthcare. When used in combination with quartz glass, which has high transmissivity of deep ultraviolet wavelengths, and AuSn sealant, which has excellent airtightness and durability, however, problems with cracking of the quartz glass and metallization[2] separation can occur. These glass lids, made of quartz glass with AuSn solder, employ proprietary Tanaka Kikinzoku Kogyo technologies that properly control the shape and dimensions when applying the AuSn sealant to the quartz glass, making it possible to control cracking and metallization separation. Higher yields are expected to contribute to improved productivity and lower costs.

    Advantages of Ske-Lid

    - By using SKe-Lid as a cover material for quartz glass (also compatible with glass with AR codes), the transmissivity of high-output deep ultraviolet LEDs can be increased.
    - When using quartz glass with AuSn, the AuSn solder is already applied to the glass, facilitating the positioning with the ceramic package during sealing.
    - AuSn airtight sealing raises reliability and durability.
    - The use of proprietary technology controls the formation of cracks during application of AuSn to quartz glass with high transmissivity of deep ultraviolet wavelengths and ceramic package sealing.

    Because of these advantages provided by Ske-Lid, it is expected to contribute to higher productivity and lower costs of final products in the deep ultraviolet LED market, which will require higher outputs and reliability in the future. As the shift to SMD[3] proceeds and advances are made in autonomous vehicles, AuSn sealing will likely be used in semiconductor lasers, which require high reliability and durability, and devices that require transparent covering materials such as automotive sensors.

    Background to development

    As a result of the Minamata Convention on Mercury coming into effect in August 2017, development of deep ultraviolet LEDs is proceeding as a replacement for mercury lamps used for water and air disinfection.

    When deep ultraviolet LEDs are manufactured using conventional resin sealants, the ultraviolet rays cause degradation of the resin sealants, resulting in deterioration of device properties and lifespan. Also, when AuSn solder, which is highly resistant to ultraviolet rays, is used as the sealant material, cracks occur in the quartz glass and metallization separation occurs due to thermal expansion between the package ceramics, window quartz glass, and AuSn sealant, giving rise to low yields.

    Tanaka Kikinzoku Kogyo adopted proprietary technologies that adequately control the shape and dimensions when applying AuSn sealant to quartz glass and successfully developed a high-quality quartz glass lid with AuSn that monitors the occurrence of cracking and produces an airtight seal. Ske-Lid was developed with cooperation from Kyocera Corporation, Yamamura Photonics Co., Ltd., and Asahi Glass Co., Ltd., which provided the glass material and ceramic package material, and CROSS OSAKA Co., Ltd., which performed the seal testing.

    Tanaka Kikinzoku Kogyo will display Ske-Lid at the OPTICS & PHOTONICS International Exhibition 2018 (OPIE '18) at the Pacifico Yokohama from April 25 to 27.

    Cooperating Partners
    Kyocera Corporation: ALN ceramic package
    Asahi Glass Co., Ltd.: LTCC (GCHP TM) ceramic package
    Yamamura Photonics Co., Ltd.: Quartz glass
    CROSS OSAKA Co., Ltd.: Seal device evaluation

    [1] Deep ultraviolet: Also referred to as UVC. Has a wavelength from 250 nm to 280 nm. Has strong disinfecting effects.
    [2] Metallization: A technology for coating non-metallic surfaces with a metal. Ceramics and other materials that have been metalized form an electric circuit and are used during soldering and for different applications.
    [3] SMD: An abbreviation for surface mount device. Refers to electronic components manufactured in such a way that they can be mounted merely by soldering them to the surface of a printed circuit board. SMDs make it possible to miniaturize and increase the density of electronic components such as LED chips.

    Press release (PDF):http://www.acnnewswire.com/clientreports/598/180402_EN.pdf

    Tanaka Holdings Co., Ltd. (Holding company of Tanaka Precious Metals)

    Headquarters: 22F, Tokyo Building, 2-7-3 Marunouchi, Chiyoda-ku, Tokyo
    Representative: Akira Tanae, Representative Director & CEO
    Founded: 1885
    Incorporated: 1918*
    Capital: 500 million yen
    Employees in consolidated group: 5,120 (FY2016)
    Net sales of consolidated group: 1,064,259 million yen (FY2016)
    Main businesses of the group: Strategic and efficient group management and management guidance to group companies as the holding company at the center of the Tanaka Precious Metals.
    Website:http://www.tanaka.co.jp/english (Tanaka Precious Metals),http://pro.tanaka.co.jp/en (Industrial products)
    * Tanaka Holdings adopted a holding company structure on April 1, 2010.

    Tanaka Kikinzoku Kogyo K.K.

    Headquarters: 22F, Tokyo Building, 2-7-3 Marunouchi, Chiyoda-ku, Tokyo
    Representative: Akira Tanae, Representative Director & CEO
    Founded: 1885
    Incorporated: 1918
    Capital: 500 million yen
    Employees: 2,269 (as of March 31, 2017)
    Sales: 1,059,003.329 million yen (FY2016)
    Main businesses: Manufacture, sales, import and export of precious metals (platinum, gold, silver, and others) and various types of industrial precious metals products.

    About the Tanaka Precious Metals

    Since its foundation in 1885, the Tanaka Precious Metals group has built a diversified range of business activities focused on precious metals. Tanaka is a leader in Japan regarding the volumes of precious metals handled. Over the course of many years, Tanaka Precious Metals has not only manufactured and sold precious metal products for industry but also provided precious metals in such forms as jewelry and resources. As precious metals specialists, all Group companies within and outside Japan work together with unified cooperation between manufacturing, sales, and technological aspects to offer products and services. Besides, to make further progress in globalization, Tanaka Kikinzoku Kogyo welcomed Metalor Technologies International SA as a member of the Group in 2016.

    As precious metal professionals, Tanaka Precious Metals will continue to contribute to the development of an enriching and prosperous society.

    The five core companies in the Tanaka Precious Metals are as follows.
    - Tanaka Holdings Co., Ltd. (pure holding company)
    - Tanaka Kikinzoku Kogyo K.K.
    - Tanaka Denshi Kogyo K.K.
    - Electroplating Engineers of Japan, Limited
    - Tanaka Kikinzoku Jewelry K.K.

    Press inquiries
    Tanaka Holdings Co., Ltd.

    - ASIA TODAY News Global Distribution http://www.AsiaToday.com

    Company JCN Newswire
    Contact Tiara Liu
    Telephone +81-3-5791-1821
    E-mail info@japancorp.net